Tag: biopharma

HANSIZHUANG (serplulimab) was the first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC

In an exclusive interview, Siddharth Daga, Managing Director, VINS Bioproducts shared his views on his company’s operations, product portfolio, latest industry trends and outlook

Biopharmaceutical companies are now focusing on advancing these drugs to enhance efficacy and expand their therapeutic scope beyond type 2 diabetes and obesity

The Cover Story focuses on India's crucial role in ensuring global vaccine security with an exclusive interview of Dr Krishna Ella, Executive Chairman, Bharat Biotech & President, Indian Vaccine Manufacturers Association. Read interviews of Sriram Natarajan, CEO, Molbio Diagnostics and Dr Renuka Diwan, CEO, BioPrime Agrisolutions. Also features Expert Insights, Special Story and Startup Special.

Recognition of Avantor's achievements in downstream processing, single-use systems, and its overall leadership as a biopharma supplier in Korea

Bharat Biotech's collaboration with MSD, Wellcome-Trust Hilleman Laboratories aims to address the critical shortage of OCVs

High performance biomanufacturing is the ability to produce products from medicine to materials, address farming and food challenges, and promote manufacturing of bio-based products

National Biopharma Mission (NBM) achieved a milestone by launching 18 successful products and 200 grantees in Vaccines, Biotherapeutics & Medical Devices and Diagnostics

The Supreme Court considered the arguments on merits and dismissed the writ petition on the ground that this is a roving inquiry and the petitioner failed to disclose the entire facts before the Court

The successful completion of the global Phase 3 trials paves the way to obtain marketing approval in the U.S. and EU